Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: U.S.

SPDR S&P Pharmaceuticals ETF

+ Add to Watchlist

XPH:US

123.6800 USD 1.0500 0.84%

As of 18:40:01 ET on 02/27/2015.

Snapshot for SPDR S&P Pharmaceuticals ETF (XPH)

Open: 124.9400 High - Low: 125.4700 - 123.6300 Primary Exchange: NYSE Arca
Volume: 101,364 52-Week Range: 81.4015 - 125.4700 Beta vs SPSIPHTR: 1.0031

ETF Chart for XPH

No chart data available.
  • XPH:US 123.6800
  • 1D
  • 1M
  • 1Y
124.7300
Interactive XPH Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for XPH

SPDR Pharmaceuticals ETF is an exchange-traded fund incorporated in the USA. The Fund's objective is to replicate as closely as possible the performance of the S&P Pharmaceuticals Select Industry Index, an equal-weighted index.

Inception Date: 2006-06-22 Telephone: 1-866-787-2257
Managers: JOHN A TUCKER / MICHAEL FEEHILY
Web Site: www.spdrs.com

Fundamentals for XPH

NAV (on 2015-02-26) 124.6722
Assets (M) (on 2015-02-26) 1,122.0670
Shares out (M) 9.00
Market Cap (M) 1,113.14
% Premium 0.05
Average 52-Week % Premium 0.0175
Fund Leveraged N

Dividends for XPH

Dividend Type Long Term Cap Gain
Dividend Frequency Quarter
Last Dividend Net (on 2014-12-19) 2.4324
Dividend Yield (ttm) 4.85%

Performance for XPH

1-Month +9.25% 1-Year +30.60%
3-Month +13.64% 3-Year +35.17%
Year To Date +15.53% 5-Year +29.18%
Expense Ratio 0.35

Top Fund Holdings for XPH

Filing Date: 02/25/2015
Name Position Value % of Total
Salix Pharmaceuticals Ltd 289,354 45,333,091 4.116%
Depomed Inc 1,973,808 44,450,156 4.036%
Lannett Co Inc 686,174 44,066,094 4.001%
Horizon Pharma Plc 2,352,702 43,901,419 3.986%
Hospira Inc 495,614 43,361,269 3.937%
Theravance Inc 2,233,173 40,465,095 3.674%
Pacira Pharmaceuticals Inc/DE 328,232 39,148,231 3.554%
Impax Laboratories Inc 959,562 39,054,173 3.546%
Endo International PLC 434,902 37,049,301 3.364%
Mallinckrodt PLC 315,699 36,668,439 3.329%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil